Practical Geriatrics ›› 2026, Vol. 40 ›› Issue (7): 714-719.doi: 10.3969/j.issn.1003-9198.2026.07.013
Previous Articles Next Articles
LIU Mingjie, ZHANG Yuling, SUN Wanting, MA Shuyue, ZENG Lanting, LU Jun, XU Guangxu
Received:2026-01-20
Published:2026-07-21
Contact:
XU Guangxu, Email:xuguangxu1@126.com
CLC Number:
LIU Mingjie, ZHANG Yuling, SUN Wanting, MA Shuyue, ZENG Lanting, LU Jun, XU Guangxu. Randomized controlled trial on extracorporeal shock wave therapy for focal muscle hypertonia and motor function in elderly patients with Parkinson’s disease[J]. Practical Geriatrics, 2026, 40(7): 714-719.
| [1] HANSEN C A, MILLER D R, ANNARUMMA S, et al. Levodopa-induced dyskinesia: a historical review of Parkinson’s disease, dopamine, and modern advancements in research and treatment[J]. J Neurol, 2022, 269(6): 2892-2909. [2] RUONALA V, PEKKONEN E, AIRAKSINEN O, et al. Levodopa-induced changes in electromyographic patterns in patients with advanced Parkinson’s disease[J]. Front Neurol, 2018, 9: 35. [3] SIVANANDY P, LEEY T C, XIANG T C, et al. Systematic review on Parkinson’s disease medications, emphasizing on three recently approved drugs to control Parkinson’s symptoms[J]. Int J Environ Res Public Health, 2021, 19(1): 364. [4] SUKHANOV I, DOROTENKO A, FESENKO Z, et al. Inhibition of PDE10A in a new rat model of severe dopamine depletion suggests new approach to non-dopamine Parkinson’s disease therapy[J]. Biomolecules, 2022, 13(1): 9. [5] SCHMIDT F A, MARTINEZ-TORRES I, GERMANN J, et al. Disparities in access to deep brain stimulation[J]. Stereotact Funct Neurosurg, 2026, 104(2):101-107. [6] LU Q Q, ZHU P A, LI Z L, et al. Efficacy of repetitive transcranial magnetic stimulation over the supplementary motor area on motor function in Parkinson’s disease: a meta-analysis[J]. Am J Phys Med Rehabil, 2025, 104(4): 318-324. [7] ZHANG H L, JIN R J, GUAN L, et al. Extracorporeal shock wave therapy on spasticity after upper motor neuron injury: a systematic review and meta-analysis[J]. Am J Phys Med Rehabil, 2022, 101(7): 615-623. [8] LUO S, GOETZ C G, CHOI D, et al. Resolving missing data from the movement disorder society unified Parkinson’s disease rating scale: implications for telemedicine[J]. Mov Disord, 2022, 37(8): 1749-1755. [9] MIRABELLA G, PILOTTO A, RIZZARDI A, et al. Effects of dopaminergic treatment on inhibitory control differ across Hoehn and Yahr stages of Parkinson’s disease[J]. Brain Commun, 2024, 6(1): fcad350. [10] BEARD J, WILLIAMS G, KAHN M, et al. The Modified Ashworth and Modified Tardieu Scales differ in their classification of lower limb spasticity[J]. Clin Rehabil, 2025, 39(6): 2692155251337306. [11] PRAMUAN P, ASAWABHARUJ J, SIRIPHORN A. Comparative accuracy of the figure-of-eight walk test and 10-meter walk test in classifying walking abilities in stroke survivors[J]. J Bodyw Mov Ther, 2025, 45: 1106-1111. [12] MANCA A, CEREATTI A, BAR-ON L, et al. A survey on the use and barriers of surface electromyography in neurorehabilitation[J]. Front Neurol, 2020, 11: 573616. [13] 齐文亮, 陈蒙, 王宇航, 等. 表面肌电图对青年卒中患者偏瘫步态的评价作用[J]. 中国现代神经疾病杂志, 2025, 25(8): 717-724. [14] 向云, 刘家庆. 表面肌电评定脑卒中后肢体痉挛状态的meta分析[J]. 中国康复医学杂志, 2019, 34(8): 960-965. [15] AMATACHAYA S, NAEWLA S, SRISIM K, et al. Concurrent validity of the 10-meter walk test as compared with the 6-minute walk test in patients with spinal cord injury at various levels of ability[J]. Spinal Cord, 2014, 52(4): 333-336. [16] AYVAT F, AYVAT E, DOGÄN M, et al. Can Timed Up and Go Test discriminate the risk of falling in patients with Multiple Sclerosis with low to moderate impairment?[J]. Disabil Rehabil, 2025, 47(12): 3189-3194. [17] HONEINE J L, SCHIEPPATI M, GAGEY O, et al. The functional role of the triceps surae muscle during human locomotion[J]. PLoS One, 2013, 8(1): e52943. [18] VIALLERON T, DELAFONTAINE A, MILLERIOUX I, et al. Acute effects of short-term stretching of the triceps surae on ankle mobility and gait initiation in patients with Parkinson’s disease[J]. Clin Biomech: Bristol, 2021, 89: 105449. [19] MCKAY J L, HACKNEY M E, FACTOR S A, et al. Lower limb rigidity is associated with frequent falls in Parkinson’s disease[J]. Mov Disord Clin Pract, 2019, 6(6): 446-451. [20] MIHAI E E, DUMITRU L, MIHAI I V, et al. Long-term efficacy of extracorporeal shock wave therapy on lower limb post-stroke spasticity: a systematic review and meta-analysis of randomized controlled trials[J]. J Clin Med, 2020, 10(1): 86. [21] DE ROO E G, KOOPMAN S B, JANSSEN T W, et al. The effects of extracorporeal shock wave therapy in children with cerebral palsy: a systematic review[J]. Int J Surg, 2025, 111(4): 2773-2790. [22] LORENTZEN J, GREY M J, CRONE C, et al. Distinguishing active from passive components of ankle plantar flexor stiffness in stroke, spinal cord injury and multiple sclerosis[J]. Clin Neurophysiol, 2010, 121(11): 1939-1951. [23] GUO J, HAI H, MA Y. Application of extracorporeal shock wave therapy in nervous system diseases: a review[J]. Front Neurol, 2022, 13: 963849. [24] LENG Y, LO W L A, HU C, et al. The effects of extracorporeal shock wave therapy on spastic muscle of the wrist joint in stroke survivors: evidence from neuromechanical analysis[J]. Front Neurosci, 2020, 14: 580762. [25] SOHN M K, CHO K H, KIM Y J, et al. Spasticity and electrophysiologic changes after extracorporeal shock wave therapy on gastrocnemius[J]. Ann Rehabil Med, 2011, 35(5): 599-604. [26] SAWAN S, ABD-ALLAH F, HEGAZY M M, et al. Effect of shock wave therapy on ankle plantar flexors spasticity in stroke patients[J]. Neuro Rehabilitation, 2017, 40(1): 115-118. [27] DIETZ V, QUINTERN J, BERGER W. Electrophysiological studies of gait in spasticity and rigidity. Evidence that altered mechanical properties of muscle contribute to hypertonia[J]. Brain, 1981, 104(3): 431-449. [28] ASCI F, FALLETTI M, ZAMPOGNA A, et al. Rigidity in Parkinson’s disease: evidence from biomechanical and neurophysiological measures[J]. Brain, 2023, 146(9): 3705-3718. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
|